期刊文献+

抗人整合素αvβ3-组织因子融合蛋白基因的构建和表达 被引量:1

Construction and Expression of a Fusion Protein of a Single Chain Antibody to Human Integrin αvβ3 and Tissue Factor
下载PDF
导出
摘要 目的:利用基因工程技术构建和表达抗人整合素αvβ3单链抗体(scFv)与人可溶性组织因子(sTF)的融合蛋白scFv-sTF。方法:用重叠延伸PCR技术扩增scFv基因,同时用组装PCR方法人工合成sTF基因,然后以酶切连接方式融合2个基因,并克隆至原核表达载体pQE80L中,构建表达质粒pQE80L-scFv-sTF,以重组子转化大肠杆菌M15诱导目的基因表达。结果:SDS-PAGE分析显示工程菌可以表达相对分子质量约55×103的融合蛋白scFv-sTF,Western印迹分析证实表达的目的蛋白具有6×His标签;经低剂量IPTG诱导和较低温度培养,scFv-sTF获得了可溶性表达;纯化回收目的蛋白,ELISA试验证实,该重组抗体分子具有良好的抗原结合活性。结论:构建并表达了抗人整合素αvβ3的单链抗体融合蛋白scFv-sTF,并验证了其抗原结合活性,初步证明它可以与抗原特异性结合,为进一步研究其抗肿瘤作用打下了基础。 Objective: To construct and express a fusion protein of a single chain antibody(scFv) to human inte-grin αvβ3 and soluble human tissue factor(sTF). Methods: The scFv gene was amplified by overlapping extension PCR and the sTF gene was synthesized by assembly PCR technique, and they were joined together as a fusion gene and were cloned into the prokaryotic expression vector pQE80L to construct the expression plasmid pQE80L-scFv-sTF, which was expressed in E.coli M15. Results: SDS-PAGE analysis showed that the expressed recombined protein had a molecular weight of 55 kD. Western blot analysis confirmed that the protein was tagged with 6×His. The scFv-sTF protein was expressed as soluble protein under the condition of low concentration IPTG induction at low temperature. The reconbinant protein was purified and ELISA suggested that the recombinant fusion protein could bind to the human integrin αvβ3. Conclusion: The fusion protein scFv-sTF have been expressed, which lays the foundation for the analasis of its anti-tumor activities.
出处 《生物技术通讯》 CAS 2010年第4期488-493,共6页 Letters in Biotechnology
基金 全军"十一五"计划(06H054)
关键词 整合素ΑVΒ3 单链抗体 组织因子 融合蛋白 integrin αvβ3 single chain Fv tissue factor fusion protein
  • 相关文献

参考文献13

  • 1Brooks P C,Stromblad S,Sanders L C,et al.Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3[J].Cell,1996,85(5):683-693.
  • 2Brooks P C,Stromblad S,Klemke B,el al.Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin[J].J Clin Invest,1995,96(4):1815-1822.
  • 3Liapis H,Flath A,Kitazawa S.Integrin alpha V beta 3 expression by bone-residing breast cancer metastases[J].Diagn Mol Pathol,1996,5(2):127-135.
  • 4Sillelti S,Kessler T,Goldberg J,et al.Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo[J].Proc Natl Acad Sci USA,2001,98(1):119-124.
  • 5Wei Y Q,Wang Q R,Zhao X,et al.Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine[J].Nat Med,2000,6(10):1160-1166.
  • 6Hood J D,Bednarski M,Frausto R,et al.Tumor regression by targeted gene delivery to the neovasculature[J].Science,2002,296(5577):2404-2407.
  • 7Dienst A,Grunow A,Unruh M,et al.Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins[J].J Natl Cancer lust,21305,97:733-747.
  • 8王臣,侯利华,张彦明,李建民,廖振林,杜桂鑫,陈薇,童贻刚.抗人整合素ανβ_3 单抗E10鼠/人嵌合Fab噬菌体抗体的构建和表达[J].西北农林科技大学学报(自然科学版),2004,32(5):9-13. 被引量:3
  • 9Hoover D M,Labkowski J.DNA Works:an automated method for designing oligonucleotides for PCR-based gane synthesis[J].Nucleic Acids Res,2002,30(10):e43.
  • 10Stemmer W P,Crameri A,Ha K D,et al.Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides[J].Genes,1995;164:49-53.

二级参考文献28

  • 1朱晓峰,陈锦辉,张昕,安小平,周育森,童贻刚.用DREAM技术纠正人工合成基因中的突变[J].中国生物工程杂志,2007,27(1):86-92. 被引量:2
  • 2Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A Laboratory Manual. 3nd ed. New York: Cold Spring Harbor Laboratory Press, 2001.
  • 3Aiyar A, Xiang Y, Leis J. Site-directed mutagenesis using overlap extension PCR. Methods Mol Biol, 1996, 57(2): 177-191.
  • 4Kunkel TA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA, 1985, 82(2): 488-492.
  • 5Weiner MP, Costa GL, Schoettlin W, et al. Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction. Gene, 1994, 151(1/2): 119-123.
  • 6Li S, Wilkinson MF. Site-directed mutagenesis: a two-step method using PCR and DpnI. Biotechniques, 1997, 23(4): 588-590.
  • 7Wei D, Li M, Zhang X, Xing L. An improvement of the site-directed mutagenesis method by combination of megaprimer, one-side PCR and DpnI treatment. Anal Biochem, 2004, 331(2): 401-403.
  • 8Shenoy AR, Visweswariah SS. Site-directed mutagenesis using a single mutagenic oligonucleotide and DpnI digestion of template DNA. Anal Biochem, 2003, 319(2): 335-336.
  • 9Zhu L. In vitro site-directed mutagenesis using the unique restriction site elimination (USE) method. Methods Mol Biol, 1996, 57(1): 13-29.
  • 10Deng WP, Nickoloff JA. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal Biochem, 1992, 200(1): 81-88.

共引文献4

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部